Prevacid, Lansoprazole News

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia /PRNewswire/ -- Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for ... (more)

GlobalData estimates that the global peptic ulcer therapeutics market was worth $892.4m in 2010, and is forecast to grow at a Compound Annual Growth Rate of 2% to $1,046.2m by 2018.

HYDERABAD, India -- -- Dr. Reddy's Laboratories announced today that it has launched over-the-counter Lansoprazole delayed-release capsules in the U.S. market on May 18, 2012, following Dr.

ALLEGAN, Mich., May 18, 2012 /PRNewswire/ -- Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Lansoprazole capsules .

Perrigo has received final FDA approval for its abbreviated new drug application for Lansoprazole capsules for the treatment of frequent heartburn.

The Food and Drug Administration released its most recent list of drugs that consumers and health professionals should keep their eye on due to serious risks or new safety information.